Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Comprehensive Tissue Biorepository and Collection Services

Published: Wednesday, April 24, 2013
Last Updated: Tuesday, April 23, 2013
Bookmark and Share
AMSBIO now include blood products from human donors with auto-immune and neurological conditions.

AMSBIO has announced further expansion of its tissue biorepository and collection services to now include blood products from human donors with auto-immune and neurological conditions.

Whole blood, plasma, serum, PBMCs and cerebrospinal fluid samples are available from a wide variety of donors.

In addition AMSBIO is now able to offer collection services of patient samples that meet the demographic and medical history requirements of specific research studies.

Drawing upon over 20 years of serving this market - AMSBIO has established one of the most comprehensive ranges of tissue products to advance personalized medicine by putting these valuable samples in the hands of leading researchers.

Samples are available isolated from hundreds of different source tissues including human normal and diseased tissues, and a variety of genetic model organisms including mouse, rat, primates and plant species.

These specimens are provided ready-to-use enabling the immediate study of molecules of interest eliminating the need for time consuming in-house sample collection and preparation.

These tissue products further extend AMSBIO's extensive bank of clinical and veterinary specimens that form a unique range of specimens in formalin fixed paraffin embedded (FFPE) or snap frozen formats.

This extensive library of samples includes genomic DNA preparations, tissue specific PCR-ready first strand cDNAs, universal cDNA and 96 well and 384 well cDNA panels.

Total, universal RNA and micro and total protein lysates are also available.

All tissue products are produced using rigorous standard operating procedures and through ethical procurement to ensure only the highest quality materials.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Ready-to-Use Tagged cDNA Clones
Available from AMSBIO TrueORF®cDNA clones are tagged cDNA clones for protein studies.
Monday, June 01, 2015
AMSBIO Publishes Comprehensive Cell Culture Handbook
Extensive 48-page handbook is intended for research scientists looking to culture cells in more physiologically relevant environments.
Friday, April 04, 2014
AMSBIO & Sanguine Biosciences Announce Distribution Agreement
Agreement to distribute and support AMSBIO’s products and services throughout Europe.
Friday, August 23, 2013
Scientific News
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
Angina Drug Could Inform A New Strategy To Fight Cryptococcosis
A drug, more commonly used in the treatment of angina, could be the focus of a new strategy in fighting the fatal fungal infection cryptococcosis.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!